Patents Examined by Jon C Morales
  • Patent number: 11890470
    Abstract: An example of a system for programming a neurostimulator may include a storage device and a user interface. The storage device may be configured to store waveform building blocks. The user interface may include a display screen, a user input device, and an interface control circuit. The interface control circuit may include a waveform composer configured to allow for composition of one of more building blocks and composition of a pattern of neurostimulation pulses using selected one or more waveform building blocks. The waveform composer may include a library controller and waveform building block editors. The library controller may be configured to display a library management area on the screen. The displayed library management area allows a user to manage the stored waveform building blocks. The waveform building block editors may each be configured to allow the user to compose a type of the waveform building blocks.
    Type: Grant
    Filed: April 28, 2022
    Date of Patent: February 6, 2024
    Assignee: Boston Scientific Neuromodulation Corporation
    Inventors: David Ernest Wechter, David Lubensky, Brian Hoffer
  • Patent number: 11497919
    Abstract: This disclosure relates to a communication amplification device for an implantable capsule, in particular for an autonomous cardiac stimulation capsule. The amplification device comprises a first holding element and a second element configured to hold the implantable capsule. The first holding element is configured to receive the distal end of the capsule and the second holding element is configured to receive the proximal end of the capsule. The first holding element comprises a communication amplification antenna configured to couple to a distal electrode of the capsule.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: November 15, 2022
    Assignee: Sorin CRM SAS
    Inventors: Willy Regnier, Jean-Francois Debroux
  • Patent number: 11298083
    Abstract: An implantable cardiac monitor (ICM) and a computer implemented method are provided. The ICM includes electrodes that are configured to sense analog cardiac activity (CA) signals when engaged with tissue at a location remote from the heart. One or more of the electrodes transition between an engaged state and disengaged state with respect to the tissue. An analog to digital (A/D) converter communicates with the electrodes along a data signal path. The A/D converts the analog CA signals to digital CA signal. An electrode-tissue feedback (ETF) circuit is provided along the data signal path between the electrodes and the A/D converter. The ETF circuit generates a feedback signal component into the data signal path when one or more of the electrodes is in the disengaged state. The feedback signal component is superimposed onto the analog CA signals.
    Type: Grant
    Filed: September 16, 2019
    Date of Patent: April 12, 2022
    Assignee: PACESETTER, INC.
    Inventors: Fady Dawoud, Alan B. Vogel, Kurt Salek